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I. Purpose 
Under the NIH Guidelines for Research Involving Recombinant or Synthetic DNA Molecules 
(NIH Guidelines), each institution conducting or sponsoring recombinant or synthetic nucleic 
acid research covered by these Guidelines is responsible for ensuring that the research is 
carried out in full conformity with the provisions of the Guidelines. 
 
The institution must establish and implement policies that provide for the safe conduct of 
recombinant or synthetic nucleic acid research and ensure compliance with the Guidelines. The 
institution must also establish an Institutional Biosafety Committee (IBC) whose responsibilities 
need not be restricted to recombinant or synthetic nucleic acids. If the institution is engaged in 
recombinant or synthetic nucleic acid research requiring biosafety level-3 (BL-3) or higher 
containment or is engaged in large-scale (greater than 10 liters of culture media) research, it 
must appoint a Biological Safety Officer (BSO) who shall be a member of the IBC. 
II. Policy Statement 
The Georgia Southern University (GS) Institutional Biosafety Committee (IBC) is a committee 
appointed by the Institutional Official. The Institutional Official exercises administrative and 
operational authority to commit institutional resources, enforce policies, authorize necessary 
administrative or legal action, and otherwise ensure that UNH maintains strong and effective 
compliance programs.  As required by the NIH Guidelines, GS IBC oversees and regulates all 
research with biohazardous agents and recombinant DNA molecules for research conducted by 
GS faculty, staff, or students. The IBC has the authority and obligation to stop any activity using 
biological materials, including but not limited to recombinant DNA and infectious organisms that 
the committee believes to be unsafe. 
It is the policy of the University that all activities involving potential biohazards be conducted in a 
safe manner in order to protect laboratory workers, students, other persons, our community, and 
the environment from potentially biohazardous agents and in such a manner that projects 
conducted by one faculty member will not have an adverse effect on adjacent projects 
conducted by other scientists.  
The IBC oversees and establishes University policy for review and approval of all activities 
involving the use of recombinant DNA and potentially biohazardous materials to assure 
compliance with current regulations and guidelines. PIs and/or laboratory supervisors at GS 
who either store or carry out research or diagnostic activities involving potentially biohazardous 
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materials must inform the Institutional Biosafety Committee by submitting a Biosafety Protocol 
approval application and receiving approval prior to beginning the project.   
Further, it is University policy that no Risk Group (RG) 4 Agents may be used or stored at GS.   
No activity requiring BSL4 containment may be conducted in a GS facility.  See the NIH 
Guidelines and CDC BMBL for a list of these agents and definitions.  
III. Exclusions 
There are no exclusions to this policy. 
IV. Procedures  
Procedures for the application, review and governance of the Institutional Biosafety Committee 
are located on the Office of Research Integrity website.   
